Medtech Founders's guest appearances

Medtech Founders

Medsider: Learn from MedTech and HealthTech Experts

From Lab to Launch by Qualio

Derek Herrera

Steve Anderson

John Simpson

Scott Wolf

John Murphy

Dan Rose

Rohan Dixit

Jared Bauer

Mike Wallace

Justin Barad

Bob Paulson

Asha Parekh

David Albert

Graeme Smith

Mark Toland

OwlTail

Duane Mancini

On the show today we have Duane Mancini, CEO &amp; Managing Partner of Project MedTech and proud to be a “nerd” of the MedTech industry. Duane has extensive experience in go-to-market strategy including regulatory &amp; reimbursement, biocompatibility, pre-clinical efficacy testing, and clinical trial design &amp; execution. With all of the complexities of running a Medtech company and taking a product to the market, Duane partners with start-ups to develop strategies and milestones.He runs the Project MedTech podcast series which has over 120 episodes. We’re excited to jump more into the medtech world and what companies need from inception to market. duane.mancini@projectmedtech.com Project Medtech Webpage Project Medtech LinkedInDuane Mancini LinkedInQualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

On the show today we have Duane Mancini, CEO &amp; Managing Partner of Project MedTech and proud to be a “nerd” of the MedTech industry. Duane has extensive experience in go-to-market strategy including regulatory &amp; reimbursement, biocompatibility, pre-clinical efficacy testing, and clinical trial design &amp; execution. With all of the complexities of running a Medtech company and taking a product to the market, Duane partners with start-ups to develop strategies and milestones.He runs the Project MedTech podcast series which has over 120 episodes. We’re excited to jump more into the medtech world and what companies need from inception to market.  <a href="mailto:duane.mancini@projectmedtech.com">duane.mancini@projectmedtech.com</a> <a href="http://www.projectmedtech.com/" rel="nofollow" target="_blank">Project Medtech Webpage </a><a href="https://www.linkedin.com/company/project-medtech-podcast/?viewAsMember=true" rel="nofollow" target="_blank">Project Medtech LinkedIn</a><a href="https://www.linkedin.com/in/duanemancini/" rel="nofollow" target="_blank">Duane Mancini LinkedIn</a>Qualio website: <a href="https://www.qualio.com/" rel="nofollow" target="_blank">https://www.qualio.com/ </a> Previous episodes: <a href="https://www.qualio.com/from-lab-to-launch-podcast" rel="nofollow" target="_blank">https://www.qualio.com/from-lab-to-launch-podcast </a> Apply to be on the show: <a href="https://forms.gle/uUH2YtCFxJHrVGeL8" rel="nofollow" target="_blank">https://forms.gle/uUH2YtCFxJHrVGeL8 </a> Music by keldez

What all MedTech Founders Should Know with Duane Mancini CEO of Project MedTech

Renee Ryan

We recently caught up with Renee Ryan, the CEO of Cala Health, a bioelectronic medicine company that’s focused on wearable neuromodulation therapies that deliver individualized peripheral nerve stimulation. Renee has 25 years of experience in healthcare as an executive and investor, and in this episode, she shares her expertise with the Medsider community. Renee will discuss some common mistakes that medtech startups make, and talk about what she looks for as an investor in early-stage companies. She shares tips on navigating the regulatory waters and obtaining insurance coverage &amp; reimbursement. Renee also gives us some key learnings from her time at Johnson &amp; Johnson, and talks about what’s new at Cala Health, including their recent FDA breakthrough device designation. But first, here’s a bit more on Renee’s background:She has 25 years of experience in the healthcare space. Previously, Renee led the medical technology investments for Johnson &amp; Johnson Innovation on the West Coast and Asia Pacific for 8 years. While at J&amp;J, she made over 15 new investments, including the Series A for Cala Health. Prior to her time at J&amp;J, she was a healthcare investment banker at RW Baird, Jefferies, and Goldman Sachs. Renee has a great eye for innovation, and we’re excited to welcome her to Medsider today. Before we jump into the conversation, I wanted to mention a few things:First, I’m trying something a little different with this next series of Medsider interviews, which will be focused entirely on stories from some of the most compelling medtech and healthtech startups across the globe. Here's the deal: I’ve asked these founders and CEOs to answer a series of questions, which I’ve converted to audio stories with the help of some professional voiceover artists. Think of these conversations almost like recorded fireside chats that you might find on Audible. They’re short and sweet, but packed with tons of great insights.I’ve never tried this before, so let me know what you think!Second, if you’re into learning from proven medtech and healthtech experts, and want to know when the next interview goes live, head over to Medsider.com. You can sign up for our totally free newsletter, which includes access to certain types of gated articles as well as regular content updates. Lastly, here's the link to the full interview if you'd rather read it instead.

We recently caught up with <a href="https://www.linkedin.com/in/renee-ryan-251b161/" rel="nofollow" target="_blank">Renee Ryan</a>, the CEO of <a href="https://calahealth.com" rel="nofollow" target="_blank">Cala Health</a>, a bioelectronic medicine company that’s focused on wearable neuromodulation therapies that deliver individualized peripheral nerve stimulation. Renee has 25 years of experience in healthcare as an executive and investor, and in this episode, she shares her expertise with the Medsider community. Renee will discuss some common mistakes that medtech startups make, and talk about what she looks for as an investor in early-stage companies. She shares tips on navigating the regulatory waters and obtaining insurance coverage &amp; reimbursement. Renee also gives us some key learnings from her time at Johnson &amp; Johnson, and talks about what’s new at Cala Health, including their recent FDA breakthrough device designation. But first, here’s a bit more on Renee’s background:She has 25 years of experience in the healthcare space. Previously, Renee led the medical technology investments for Johnson &amp; Johnson Innovation on the West Coast and Asia Pacific for 8 years. While at J&amp;J, she made over 15 new investments, including the Series A for Cala Health. Prior to her time at J&amp;J, she was a healthcare investment banker at RW Baird, Jefferies, and Goldman Sachs. Renee has a great eye for innovation, and we’re excited to welcome her to Medsider today. Before we jump into the conversation, I wanted to mention a few things: First, I’m trying something a little different with this next series of Medsider interviews, which will be focused entirely on stories from some of the most compelling medtech and healthtech startups across the globe. Here's the deal: I’ve asked these founders and CEOs to answer a series of questions, which I’ve converted to audio stories with the help of some professional voiceover artists. Think of these conversations almost like recorded fireside chats that you might find on Audible. They’re short and sweet, but packed with tons of great insights.I’ve never tried this before, so let me know what you think!Second, if you’re into learning from proven medtech and healthtech experts, and want to know when the next interview goes live, head over to <a href="https://medsider.com/" rel="nofollow" target="_blank">Medsider.com</a>. You can sign up for our totally free newsletter, which includes access to certain types of gated articles as well as regular content updates. Lastly, here's the <a href="https://medsider.com/renee-ryan-cala-health" rel="nofollow" target="_blank">link to the full interview</a> if you'd rather read it instead.

Why Medtech Founders Should Not Over-Focus on Dilution: Interview with Renee Ryan, CEO of Cala Health